Skip to main content
Caplight Logo









Riva Therapeutics

Riva Therapeutics

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://rivatherapeutics.com/

Last Round

Series A

Jun 22, 2024

Total Funding Raised

$3M

Company Overview

Riva Therapeutics is a drug discovery company developing a new generation of small-molecule therapeutics to selectively target essential tumor cell processes.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Precision Medicine, Biotechnology

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

synthetic lethalityprecision oncologysmall-molecule drugsdrug discoveryoncology therapeuticspreclinical stagegenomic dependenciesundruggable targetsDNA damage repairDDRprecision lethal therapiesbiotechnology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Riva Therapeutics Comparables

Compare Riva Therapeutics with similar companies based on industry and business-model similarity.

Riva Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tessellate BIO
83%
Z Prime Therapeutics
81%
Artios Pharma
76%

Riva Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 22, 2024
SeedJun 1, 2022

Key People

Founding team and executive leadership

John Farnam

Chief Operating Officer

Executive Team

Riva Therapeutics Investors

Notable investors and investment history

Riva Therapeutics investors
InvestorRounds
Meritz Securities Co., Ltd.Series A
Skyline VenturesSeed
Novo HoldingsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2024

    $3M round led by Meritz Securities Co., Ltd.

  • Jun 1, 2022

    Novo Holdings and Skyline Ventures participated in the round.

Riva Therapeutics Filings

Explore SEC and related filing metadata, where available.

Riva Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Riva Therapeutics's valuation, stock price, and market status.

Is Riva Therapeutics a public or private company?

Riva Therapeutics is a private company.

What is the current stock price of Riva Therapeutics?

Riva Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Riva Therapeutics worth (valuation)?

Valuation information for Riva Therapeutics is not publicly available.

Can I buy Riva Therapeutics stock?

Riva Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Riva Therapeutics's last funding round?

Funding round information for Riva Therapeutics is not publicly available.

Who are the main investors in Riva Therapeutics?

Investor information for Riva Therapeutics is not publicly disclosed.

Will Riva Therapeutics IPO soon?

No public IPO plans have been announced for Riva Therapeutics.

How can I track Riva Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Riva Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Year Founded2022
Last FundingJun 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?